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Abstract
Background: The aim of this study was to identify key genes and novel potential therapeutic targets related to
gastric cancer (GC) by comparing cancer tissue samples and healthy control samples using DNA microarray analysis.
Methods: Microarray data set GSE19804 was downloaded from Gene Expression Omnibus. Preprocessing and
differential analysis were conducted with of R statistical software packages, and a number of differentially expressed
genes (DEGs) were obtained. Cluster analysis was also done with gene expression values. Functional enrichment
analysis was performed for all the DEGs with DAVID tools. The significantly up- and downregulated genes were
selected out and their interactors were retrieved with STRING and HitPredict, followed by construction of networks.
For all the genes in the two networks, GeneCodis was chosen for gene function annotation.
Results: A total of 638 DEGs were identified, and we found that SPP1 and FABP4 were the markedly up- and
downregulated genes, respectively. Cell cycle and regulation of proliferation were the most significantly
overrepresented functional terms in up- and downregulated genes. In addition, extracellular matrix–receptor
interaction was found to be significant in the SPP1-included interaction network.
Conclusions: A range of DEGs were obtained for GC. These genes not only provided insights into the
pathogenesis of GC but also could develop into biomarkers for diagnosis or treatment.
Keywords: Differentially expressed gene, Functional enrichment analysis, Gastric cancer, Interaction network,
Pathway analysis
Background
Gastric cancer (GC) is one of the most prevalent cancers
in the world. Recognized risk factors for GC include in-
fection with Helicobacter pylori, dietary factors, smoking
and other factors [1]. Molecular genetics and molecular
biology studies have shown that the pathogenesis of GC
is a progressive process involving multiple steps and fac-
tors. The activation, overexpression or amplification of
oncogenes and the deletion or mutation of tumor sup-
pressor genes play important roles in the development
of GC [2]. Molecularly targeted therapy holds promise
and thus has become a focus in the field of cancer treat-
ment in recent years [3]. Biomarkers can be used clinically
to predict the effectiveness and toxicity of anticancer drugs
and thus help to achieve individualized treatment [4].
Ryu et al. found seven overexpressed proteins and seven
underexpressed proteins in GC by using a proteomics
approach [5]. Jang et al. also tried to identify biomarker
candidates by analyzing proteome profiles [6]. Yasui et al.
performed serial analysis of gene expression to search for
new biomarkers [7]. Accordingly, quite a few potential
biomarkers have been reported, such as regenerating gene
family member 4 [8], olfactomedin [9], resistin and visfatin
[10]. However, current knowledge is not sufficient to
conquer the disease clinically.
Microarray technology is a powerful tool with which
to discover the comprehensive changes in the incidence
and development of cancer [11]. Therefore, in this study,
gene expression profiles of GC tissue samples and healthy
controls were compared to identify differentially expressed
genes (DEGs). By combining functional enrichment ana-
lysis and interaction network analysis in our study, we
sought not only to provide insights into the pathogenesis
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of GC but also to discover potential biomarkers for
the diagnosis and treatment of GC.
Methods
Microarray data
Microarray data set GSE2685 [12] was downloaded from
Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/
geo/) [GEO:GSE2685], including 22 GC samples and 8
healthy controls. The GLP80 [Hu6800] Affymetrix Human
Full Length HuGeneFL Array (Affymetrix, Santa Clara,
CA, USA) and the annotation information of probes
were used to detect the gene expression.
Differential expression analysis
Raw data were converted into recognizable format, and
missing values were imputed [13]. After data normalization
[14], the multtest package [15] of R software was chosen
to perform statistical analysis to identify the DEGs by
Figure 1 Boxplot for normalized gene expression data and cluster analysis results. (a) Boxplot of gene expression data. The medians are
almost at the same level, indicating high normalization performance. (b) Cluster analysis results for gene expression data. The expression values
clustered in the purple/magenta-shaded areas indicate overexpression, and the green-shaded areas indicate underexpression.
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comparing them with healthy tissues, and multiple test-
ing correction was done using the Benjamini-Hochberg
method [16]. A false discovery rate (FDR) less than 0.05
and an absolute log fold change (|logFC|) greater than 1
were set as the significant cutoffs.
Cluster analysis
Cluster analysis [17] was conducted on the basis of the
gene expression values in each sample to verify the dif-
ference in gene expression between GC tissue samples
and healthy controls.
Functional enrichment analysis for all differentially
expressed genes
Functional enrichment analysis is able to reveal biological
functions based upon DEGs [18]. Therefore, in the present
study, we chose to use the web-based DAVID database
(Database for Annotation Visualization and Integrated Dis-
covery) for functional annotation bioinformatics micro-
array analysis [19] to determine the functional enrichment
and the Gene Ontology (GO) annotation, with P < 0.05
were selected as the significant functions.
Construction of interaction network
Proteins usually interact with each other to display certain
functions [20]. Therefore, interactors of the most signifi-
cant DEGs were predicted, including the upregulated
DEGs and downregulated DEGs using STRING (Search
Tool for the Retrieval of Interacting Genes/Proteins) [21]
and HitPredict software [22], then the interaction networks
of the significantly upregulated DEGs and downregulated
DEGs, respectively, with their interactors were established.
STRING connects major databases and predicts interac-
tions based upon experiments, text mining and sequence
homology. HitPredict collects interactions from databases
such as IntAct (EMBL-European Bioinformatics Institute,
Cambridge, UK) [23], BioGRID (Biological General Re-
pository for Interaction Datasets) and HPRD (Human
Protein Reference Database) [24], as well as from those
predicted by algorithms [22]. The interaction network from
HitPredict, which we obtained from experiments and
the likelihood score greater than 1, were considered
high-confidence interactions [25]. Interaction networks from
STRING were obtained with a high degree of confidence.
Functional enrichment analysis for all genes in the network
To explore the biological functions of all genes in the net-
work we obtained previously, we chose GeneCodis soft-
ware [26] for functional enrichment analysis. P < 0.05 was
applied as the cutoff value for significance.
GeneCodis (Gene Annotations Co-occurrence Discovery)
is a web-based tool used for gene functional analysis
[27-29]. It integrates different information resources (GO,
KEGG (Kyoto Encyclopedia of Genes and Genomes) and
Swiss-Prot gene accession databases) to seek the anno-
tation of genes and arrange their biological functions
according to their significance.
Results
Differentially expressed genes
Normalized gene expression data are shown in Figure 1a.
Good normalization performance was achieved. A total
of 638 DEGs were screened out in GC samples com-
pared with healthy controls, including 225 upregulated
DEGs and 413 downregulated DEGs.
Cluster analysis results
Cluster analysis was performed with gene expression
values, and the results are shown in Figure 1b. The gene
expression of GC samples are distinguished from the
Table 1 Functional enrichment analysis of the upregulated
and downregulated differentially expressed genesa
Gene accession number Count FDR
Upregulated DEGs
[GO:0022402] Cell-cycle process 30 1.50E-05
[GO:0007049] Cell cycle 35 3.70E-05
[GO:0022403] Cell-cycle phase 24 1.43E-04
[GO:0000278] Mitotic cell cycle 22 3.82E-04
[GO:0007155] Cell adhesion 30 0.00146
[GO:0022610] Biological adhesion 30 0.001503
[GO:0006928] Cell motion 24 0.001626
[GO:0042981] Regulation of apoptosis 32 0.00271
[GO:0043067] Regulation of programmed cell death 32 0.003334
[GO:0010941] Regulation of cell death 32 0.0036
[GO:0006259] DNA metabolic process 24 0.004784
[GO:0009611] Response to wounding 24 0.010324
[GO:0001501] Skeletal system development 18 0.013141
[GO:0051301] Cell division 17 0.0199
[GO:0051726] Regulation of cell cycle 18 0.021567
Downregulated DEGs
[GO:0042127] Regulation of cell proliferation 48 3.72E-04
[GO:0008284] Positive regulation of cell proliferation 32 4.67E-04
[GO:0006873] Cellular ion homeostasis 30 5.59E-04
[GO:0006955] Immune response 43 0.001061657
[GO:0055080] Cation homeostasis 25 0.001479293
[GO:0019226] Transmission of nerve impulse 27 0.005126019
[GO:0019725] Cellular homeostasis 32 0.005850539
[GO:0007610] Behavior 32 0.006669845
[GO:0007586] Digestion 13 0.009844162
[GO:0006875] Cellular metal ion homeostasis 19 0.010226535
[GO:0055065] Metal ion homeostasis 19 0.019086885
[GO:0030003] Cellular cation homeostasis 21 0.031550799
[GO:0007268] Synaptic transmission 23 0.033256699
aDEG, differentially expressed gene; FDR, false discovery rate.
Jin and Da European Journal of Medical Research 2013, 18:37 Page 3 of 7
http://www.eurjmedres.com/content/18/1/37
healthy controls, indicating that obvious differences existed
between the two groups.
Functional enrichment analysis results for differentially
expressed genes
The functional enrichment analysis was conducted for
upregulated and downregulated DEGs, respectively. The
results showed that 15 and 13 terms, respectively, were
significantly enriched (Table 1). Cell-cycle process (FDR =
1.50E-05), cell cycle (FDR = 3.70E-05), cell adhesion
(FDR = 0.00146), cell motion (FDR = 0.001626) and
regulation of apoptosis (FDR = 0.00271) were signifi-
cantly enriched among upregulated genes. Regulation of
cell proliferation (FDR = 3.72E-04), immune response
(FDR = 0.001061657) and cellular ion homeostasis (FDR =
0.010226535) were significantly enriched for downregulated
genes. For the cell-cycle process, 30 upregulated DEGs
were included, such as NIMA-related kinase 2 (NEK2),
cohesin subunit (RAD21) and thrombospondin 1 (THBS1).
For regulation of cell proliferation, 48 downregulated
DEGs, such as paired box 3 (PAX3), were contained.
Interaction networks
The most upregulated gene, SPP1, and the most down-
regulated gene, FABP4, were selected from among the
DEGs. Their expression values in each sample are shown
in Figure 2. Interactors of the two genes were retrieved
from STRING and HitPredict, then the interaction networks
were constructed (Figure 3). In total, 55 and 13 genes were
included in the networks of SPP1 and FABP4, respectively.
The SPP1 network contained integrin α11 (ITGA11), integ-
rin β5 (ITGB5), ITGA10, ITGB3 and other genes.
Functional enrichment analysis results for genes in
the networks
GeneCodis was chosen to analyze the function of all genes
in the two networks. Only eight functional annotations
were revealed in the network that included SPP1 (Table 2),
and the most significant one was extracellular matrix
Figure 2 Gene expression levels of FABP4 (a) and SPP1 (b) in each sample. (a) FABP4 is downregulated in gastric cancer (GC) tissue. (b) SPP1 is
upregulated in GC tissue.
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(ECM)-receptor interaction (FDR = 1.01E-31). SPP1 was
the most overexpressed gene in the whole pathway and
might play a key role in the pathogenesis of GC.
Discussion
Microarray data of GC samples and healthy controls
were compared to identify the DEGs in present study. A
total of 638 DEGs were obtained in GC samples. Cell-
cycle process, cell adhesion, cell motion and regulation
of apoptosis were significantly overrepresented in the
upregulated genes according to the functional enrichment
analysis, whereas regulation of cell proliferation, immune
response and cellular ion homeostasis were enriched in
the downregulated genes.
Proliferation, cell cycle, immune response and apoptosis
are closely associated with cancer. Many factors, such as
Figure 3 Interaction networks including FABP4 or SPP1. (a) The network that involved FABP4 based on HitPredict database, with the green
lines indicating high-confidence, small-scale binary; the blue lines indicating high-confidence, small-scale–derived; the black lines indicating
high-confidence, high-throughput; and the dashed black lines indicating spurious small-scale or high-throughput. (b) The network that
involved SPP1 based on the STRING database.
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oncogenes and tumor suppressors, have been found to be
involved in the regulation of cell cycle, and abnormalities
in relevant genes contribute to the incidence of cancer
[30]. The immune system is a critical defense, and its dys-
function results in cancer. People have put in considerable
effort to disclose the mechanisms of immune escape
[31,32]. The functional enrichment analysis results in this
study confirmed the reliability of our findings, and many
of them have been implicated in various cancers.
In addition, some key genes were screened as the DEGs
and were involved in significant functions of the DEGs.
In the cell-cycle process, for example, NEK2 encoded a
serine/threonine protein kinase that was involved in
mitotic regulation. It was associated with chromosome
instability [33] and incidence of cancers [34]. RAD21
was involved in the repair of DNA double-strand breaks,
and its deregulation was previously reported in endo-
metrial cancer and oral squamous cell carcinoma [35,36].
Atienza et al. also indicated that suppression of RAD21
gene expression can decrease growth of breast cancer cells
[37]. THBS1 is a glycoprotein that mediates cell-to-cell
and cell-to-matrix interactions and plays a role in tumori-
genesis. Lin et al. reported that polymorphism of THBS1
rs1478604 A > G in the 5′-untranslated region is associ-
ated with lymph node metastasis of GC [38]. Although
it regulates cell proliferation, PAX3 was found to trig-
ger neoplastic development by maintaining cells in a
deregulated, undifferentiated and proliferative state, and
it has become a target for cancer immunotherapy [39].
Thus, our findings might provide directions for future
research.
SPP1 was the most significantly upregulated gene, and
FABP4 was the most significantly downregulated gene;
therefore, network analysis was conducted for the two
genes to mine more information. ECM-receptor inter-
action was significantly enriched in the network includ-
ing SPP1. In fact, ECM is a macromolecular network
comprising collagen, noncollagenous glycoprotein, gly-
cosaminoglycan, proteoglycan, elastin and others. ECM
was found to influence cell survival, death, proliferation
and differentiation as well as cancer metastasis [40].
In addition, several subunits of integrin were included
in the SPP1 network, such as ITGA11, ITGB5, ITGA10,
ITGB3 and others. Integrins played important roles in
cell adhesion and signal transduction. The integrin family
regulated a range of cellular functions, which were crucial
to the initiation, progression and metastasis of solid tu-
mors [41]. ITGB3 was identified as a key regulator in
reactive oxygen species–induced migration and inva-
sion of colorectal cancer cells [42]. ITGB1 presented
certain prognostic value for patients with GC [43]. ITGB8
silencing could reduce the potential metastasis of lung
cancer cells [44]. Moreover, the ITGA2 gene C807T poly-
morphism was associated with the risk of GC [45]. There-
fore, we thought these genes were also worthy of further
research to uncover their potential effects in the diagnosis,
prognosis and treatment of GC.
Conclusions
Overall, a range of DEGs were obtained through com-
paring gene expression profiles of GC samples with
healthy controls. These genes might play important roles
in the pathogenesis of GC according to the functional
enrichment analysis, especially SPP1, which was closely
associated with ECM-receptor interaction. Of course, more
research is needed to confirm their potential function in
clinical applications.
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